BrainChild hauls in $116M to make cell therapies for childhood brain cancers

1 source ·1 article ·Sep 8, 11:00 UTC Avis Budget

Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly pediatric cancer into mid-stage testing.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·Sep 8, 11:00 UTC

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly pediatric cancer into mid-stage testing.

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

BrainChild hauls in $116M to make cell therapies for childhood brain cancers →

BrainChild hauls in $116M to make cell therapies for childhood brain cancers